Dementia Index Shows Validity for Predicting Age of Onset of MCI, Alzheimer Disease
By Elana Gotkine HealthDay Reporter
MONDAY, Jan. 13, 2025 -- The Florey Dementia Index (FDI) is valid for predicting the age of onset of mild cognitive impairment (MCI) and Alzheimer disease (AD), according to a study published online Jan. 8 in JAMA Network Open.
Chenyin Chu, from The Florey Institute of Neuroscience and Mental Health in Parkville, Australia, and colleagues examined whether age at onset of MCI and AD can be predicted in a prognostic study using data from two aging and dementia cohort studies for model development and validation of the FDI: the Australian Imaging, Biomarker and Lifestyle (AIBL) study and the Alzheimer's Disease Neuroimaging Initiative (ADNI). Data were included for 1,665 AIBL participants, 2,029 ADNI participants, and 93 participants from the Anti-Amyloid Treatment in Asymptomatic Alzheimer (A4) study.
The researchers found that the FDI achieved mean absolute errors of 2.78 and 1.48 years for predicting MCI onset and AD onset, respectively. In the simulated trial with A4 participants, the FDI achieved mean absolute errors of 1.57 and 0.70 years for predicting MCI onset and AD onset, respectively.
"The promising results achieved in the present study support the potential clinical use of the FDI model so that timely diagnostics, treatment, and care plans for individuals at risk can be arranged," the authors write.
The Alzheimer's Disease Neuroimaging Initiative is funded by contributions from biopharmaceutical companies.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
Racialized Economic Segregation Linked to Advanced Cancer Diagnosis
FRIDAY, Aug. 1, 2025 -- People living in racially and economically segregated neighborhoods are more likely to be diagnosed with advanced-stage breast and cervical cancer...
New Subtype of Diabetes Identified in Sub-Saharan Africans, Black Americans
FRIDAY, Aug. 1, 2025 -- A new diabetes subtype has been identified in Sub-Saharan Africans and Black Americans, according to a study published online July 21 in The Lancet...
Average Time to Diagnosis Is 3.5 Years Across All Types of Dementia
FRIDAY, Aug. 1, 2025 -- The mean time to diagnosis (TTD) for dementia is 3.5 years across all types of dementia, according to a review published online July 27 in the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.